By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS


Industry
Biotechnology






Company News
Amarantus BioSciences, Inc. Opens Investigational New Drug (IND) Application With The U.S. FDA Allowing The Start Of A Phase 2b Program Of Eltoprazine In Parkinson's Disease Levodopa-Induced Dyskinesia 3/26/2015 10:49:41 AM
Amarantus BioSciences, Inc. To Present At The Neurotech Investing And Partnering Conference On Tuesday, April 7, 2015 3/23/2015 9:58:29 AM
Amarantus BioSciences, Inc. To Present Positive Alzheimer's Disease Biomarker Data On The Lympro Test At The 2/23/2015 8:01:00 AM
Amarantus BioSciences, Inc. Announces First Alzheimer's Biomarker Services Collaboration For Lympro Test With Anavex Life Sciences Corp. (AVXL) 2/18/2015 8:23:07 AM
Amarantus BioSciences, Inc. Announces Publication In BRAIN Of Eltoprazine Phase 2a Clinical Study For Treating Parkinson's Disease Levodopa-Induced Dyskinesia 2/10/2015 7:34:51 AM
Amarantus BioSciences, Inc. To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 10, 2015 2/3/2015 8:38:21 AM
Amarantus BioSciences, Inc. Forms Alzheimer's Disease Diagnostics Scientific Advisory Board 1/22/2015 7:42:18 AM
Amarantus BioSciences, Inc. Announces Exclusive Option Agreement With Georgetown University To License Patent Rights For Blood Based Biomarkers For Alzheimer's Disease 1/15/2015 7:02:15 AM
Amarantus BioSciences, Inc. Announces Positive Data From 140 Subject LP-002 Clinical Study Of Lympro Test® Confirming Statistically Significant Markers For Alzheimer's 1/15/2015 7:00:54 AM
Amarantus BioSciences, Inc. To Present At Noble Financial Capital Markets' Eleventh Annual Investor Conference 1/13/2015 6:56:22 AM
12345678910...
//-->